PROteolysis Targeting Chimeras: A new cutting‐edge nanomedicine for colorectal cancer

Abstract Colorectal cancer (CRC) is a prevalent malignancy with a high mortality rate, necessitating innovative treatment strategies. PROTACs (PROteolysis Targeting Chimeras) represent a promising therapeutic approach by targeting and degrading oncogenic proteins via the ubiquitin‐proteasome pathway...

Description complète

Détails bibliographiques

Auteurs principaux:	Swastika Maitra, Nobendu Mukerjee, Dattatreya Mukherjee, Arabinda Ghosh, Athanasios T. Alexiou
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2024-08-01
Collection:	Clinical and Translational Discovery
Sujets:	colorectal cancer (CRC) exosome‐based delivery nanomedicine PROTACs (PROteolysis Targeting Chimeras) targeted protein degradation
Accès en ligne:	https://doi.org/10.1002/ctd2.337
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!